Targeting the KRAS G12C mutation in patients with advanced solid tumors.

Targeting the KRAS G12C mutation in patients with advanced solid tumors.
Clin Adv Hematol Oncol. 2019 Nov;17(11):612-614
Authors: Hong DS
PMID: 31851163 [PubMed - in process]

Source: Clinical Advances in Hematology and Oncology - December 19, 2019 Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research